Ipatasertib Active Not Recruiting Phase 2 Trials for Cancer, Breast / Neoplasms, Breast Treatment

Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02162719A Study Assessing the Safety and Efficacy of Adding Ipatasertib to Paclitaxel Treatment in Participants With Breast Cancer That Has Spread Beyond the Initial Site, and the Cancer Does Not Have Certain Hormonal Receptors